How to Navigate the Biotech Startup Network

Ohad Yosefson, PhD, Associate Director of Protein Sciences, Repertoire Immune Medicines

Nathan Young, PhD, Associate Director of Molecular and Cellular Oncology, Ikena Oncology

Megan Warner, PhD, Senior Scientist, Protein Sciences, CRISPR Therapeutics

The Boston biotech sector is booming with scientific innovation, investments, and company creation. In this session, we will chat with scientists from three different biotech companies to learn how to navigate a career in a constantly evolving company while managing expectations and responsibilities. Learn about their previous experiences and job roles and inquire about their thoughts on the biotech landscape.

Repertoire Immune Medicines is a series B funded Flagship Pioneering company seeking to rationally engineer T cell receptor (TCR)-antigen interactions. Ikena Oncology is a public company focusing on genetically defined or biomarker-driven cancer targets. CRISPR Therapeutics is a public gene editing company developing treatments for hemoglobinopathies, cancer, and diabetes. All three are clinical-stage companies at the frontline of innovation.

Session organizer: Fiona Aguilar

Tentative: hybrid mode 68-181

Otherwise, Zoom link: https://mit.zoom.us/j/95349775648

Password: MITBiology